Treatment solutions and medical devices trusted by professionals worldwide
Our Scandinavian design brings you unparalleled ease of use and patient comfort.
We value good care and want to improve the tools available in routine healthcare.
The easiest neurostimulator ever made
Sooma tDCS™ is an effective and easy-to-use solution for professionals, optimised for use in clinical routine.
The system features an intuitive workflow-based operation that is controlled with a single button. Automated safety features such as continuous contact monitoring provide the ultimate level of safety and patient comfort.
Sooma tDCS™ is the optimal tool for outcome studies. It supports double-blind condition and can be configured for multiple study protocols. Moreover, Sooma tDCS™ enables you to scale up your research with home-based, self-administered use.
Medical grade quality
Healthcare professionals deserve only the highest quality of tools. This is why we have designed and tested Sooma tDCS as a class IIa medical device.
To ensure continuous quality, the system is designed using ISO 13485 and ISO 9001 and is manufactured in Finland.
The best patient contact surface
Sooma Comfort is a family of stimulation accessories for transcranial electrical stimulation. The family consists of a head cap, stimulation electrodes and stimulation pads.
With Sooma Comfort, you are able to achieve better contact quality with faster preparation when compared to traditional rubber electrodes. The burden of a session is reduced as less time is needed in the preparation phase. Moreover, the benefits of being able to drastically improve the contact quality can really change the way we perform stimulation.
World leader in home-based neuromodulation
Sooma tDCS combined with our remote patient management software represents state-of-the-art in home-based neuromodulation. Log in with your web browser and in 2 minutes, you know how all your home-based patients are doing.
Recent news and blog posts:
What treatment outcomes tDCS gives for depression? During last few years, transcranial direct current stimulation (tDCS) has become an established treatment option for the major depressive disorder. The latest meta-analysis concluded tDCS to [...]
We are happy to announce that Sooma Oy has been accepted into the Young Innovative Companies (YIC) program of Business Finland (formerly known as TEKES or Finnish Funding Agency for Technology and Innovation). The [...]
Helsinki, Finland - December 12, 2017 Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA) approval for its leading therapeutic platform Sooma tDCS. This approval allows Sooma and its distributor Equip [...]